Global Wellness Strategies Inc.

Recent News

• Global Wellness Pharma Subsidiary Supports Cancer Therapeutic Company AVM Biotechnology

  Vancouver, British Columbia--(Newsfile Corp. - December 5, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: GWSFF) ("Global Wellness" or the "Company") pharma subsidiary is excited to work with BioMed360 a GWS medical advisor.GWS pharma subsidiary is focused on providing companies with financial, operational, and management assistance during their clinical trials phase. GWS announces that BioMed360 Solutions Corp signed a letter of intent for the 100% acquisition of AVM Biotechnology. AVM Biotechnology is developing and advancing a...

  2022-12-05 8:45 AM EST
• Global Wellness Strategies Forms Pharma Subsidiary Focused on Clinical Trials

  Vancouver, British Columbia--(Newsfile Corp. - November 17, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: GWSFF) ("Global" or the "Company") a prospect generator that provides high growth companies with financial, operational, and management assistance focused in health and wellness announces the formation of a wholly owned pharma subsidiary focused on clinical trials."Real strategic capital market partnerships are essential to assist our clients in their progression to the next level with their organic growth. Forming a pharma subsidiary...

  2022-11-17 8:30 AM EST
• Global Wellness Corporate Quarter Highlights

  Vancouver, British Columbia--(Newsfile Corp. - June 27, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") provides quarter corporate highlights.The Company quarter corporate highlights included announcing:May 12th that Global Wellness' Shanti Therapeutics was preparing for their first clinical trial with iNGENü a subsidiary of Australian leader Cannvalate. Shanti' s product suite of MDMA could be the global market winner finding a solution to the chronic puzzle of pain. iNGENü is engaged as the...

  2022-06-27 4:40 PM EDT
• Global Wellness Readies for First Clinical Trial

  Vancouver, British Columbia--(Newsfile Corp. - May 12, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (OTCQB: GWSFF) (FSE: O3X) ("Global" or the "Company") announces Shanti Therapeutics MDMA Clinical Trial Update.Shanti's product suite of MDMA could be the global market winner finding a solution to the chronic puzzle of pain. iNGENü, a subsidiary of Australian leader Cannvalate, is engaged as the CRO (clinical research organization) by the Company to conduct clinical trials for Shanti Therapeutics. The protocol is...

  2022-05-12 8:30 AM EDT
• Global Wellness Strategies Closes First Tranche of Non-Brokered Private Placement

  Vancouver, British Columbia--(Newsfile Corp. - February 22, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") is pleased to announce the first tranche closing of its non-brokered private placement (the "Offering") for gross proceeds of $588,500.The securities sold pursuant to the Offering consist of 2,977,779 units of the Issuer ("Units") at a price of CAD$0.18 per unit. Each Unit consists of one common share and one common share purchase warrant. Each whole warrant...

  2022-02-22 7:18 PM EST
• Global Wellness Strategies Signs MDMA Supply Agreement with PharmAla Biotech

  Vancouver, British Columbia--(Newsfile Corp. - February 10, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: GWSFF) ("Global" or the "Company") and their Contract Research Organization ("CRO") iNGENü (a fully owned subsidiary of Cannvalate Pty Ltd) sign supply agreement with Canada-based PharmAla Biotech (CSE: MDMA) to supply GMP MDMA for the Shanti Therapeutics upcoming clinical trial.Global Wellness' Shanti Therapeutics is a first-in-class biotech utilizing the neuromodulation properties of MDMA (aka Ecstasy) to pre-emptively treat preoperative pain. Shanti...

  2022-02-10 9:36 AM EST
• Global Wellness' Shanti Therapeutics Submits Human Research Ethics Committee (HREC) Application

  Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Global Wellness Strategies Inc. (CSE: GWS) (OTCQB: GWSFF) (FSE: O3X) ("Global" or the "Company") and Shanti Therapeutics have submitted their Human Research Ethics Committee (HREC) Application for their first-in-man trials using MDMA for its anti-nociceptive effects. The Company updates on study progress, clinical trials and submission of clinical trial paperwork for the HREC committee.Shanti Therapeutics has submitted an application to Swinburne University (Melbourne, Australia) to the University Institutional Review Board (IRB)...

  2021-11-29 8:45 AM EST
• Global Wellness' Shanti Therapeutics Files MDMA Methods Patent

  Vancouver, British Columbia--(Newsfile Corp. - November 9, 2021) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB: PNNRF) ("Global" or the "Company") updates on MDMA provisional patent applications.Shanti Therapeutics has a filed provisional patent application for the treatment of pain with MDMA. Global Wellness has acquired 100% of the share capital in Shanti Therapeutics and all its constituent intellectual property. Upon completion of the initial clinical trial, the provisional patent will be upgraded to a global PCT patent with...

  2021-11-09 9:43 AM EST
• Global Wellness' Meris Kott Speaks at Debut Lift&Co Psychedelics Business Summit

  Vancouver, British Columbia--(Newsfile Corp. - November 5, 2021) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X) (OTCQB: PNNRF) ("Global" or the "Company") is proud to announce the Company CEO Meris Kott will be speaking at the first ever Lift&Co Psychedelic Business Summit which is part of the famous Lift&Co. Expo, Canada's no. 1 cannabis conference and trade show, that is returning to the Metro Toronto Convention Centre, November 18-21, 2021.Company CEO Meris Kott will be moderating the discussion "Business...

  2021-11-05 9:57 AM EDT
• Global Wellness Strategies Shanti Therapeutics Updates and Symbol Change to GWS

  Vancouver, British Columbia--(Newsfile Corp. - October 4, 2021) - Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X4) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) ("Global" or the "Company") changes symbol to GWS and introduces Dr. Sud Agarwal BSc, MB ChB, FANZCA, the Chairman of Cannvalate Pty Ltd. and Shanti Therapeutics. His experience and expertise in the psychedelic industry will contribute significantly to our efforts in the space moving forward.GWS Symbol Change:Global Wellness Strategies Inc. "Helping you Get Well Soon" is changing its ticker symbol...

  2021-10-04 8:30 AM EDT